Pink Sheet: US FDA Drug Repurposing Pathway Will Drive Research But Faces Many Challenges

How evidence supporting drug repurposing is submitted to the FDA and who reviews it are among the issues that must be addressed, former acting Commissioner Janet Woodcock said at a recent Reagan-Udall Foundation meeting.